»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Æ®·£½ºÆå¼Ç ±â¼ú ½ÃÀåÀº 2024-2029³â 7¾ï 4,620¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 9.7%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ Æ®·£½ºÆå¼Ç ±â¼ú ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ´ÜŬ·ÐÇ×ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ÃÀå ±â¾÷µéÀÇ Áö¼ÓÀûÀÎ ±â¼ú °³¹ß, crispr/cas9 À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ Ã¤Åà Ȯ´ë¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â ´ëºñ
9.5%
CAGR
9.7%
Áõ°¡¾×
7¾ï 4,620¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â µ¿¾È Æ®·£½ºÆå¼Ç ±â¼ú ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î µà¾ó ¸®Porter's ºÐ¼®°ú °øµ¿ Æ®·£½ºÆå¼Ç ½ÇÇèÀÇ »ç¿ë Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Æ®·£½ºÆå¼Ç È¿À²ÀÇ ÃÖÀûÈ¿Í °í󸮷® Æ®·£½ºÆå¼Ç ½ºÅ©¸®´×¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤¿ë·ü¡¤±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå »óȲ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀå Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024³â
½ÃÀå Àü¸Á 2024-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
Æ®·£½ºÆå¼Ç ±â¼ú ¼¼°è ½ÃÀå 2019-2023³â
À¯Çüº° ºÎ¹® ºÐ¼® 2019-2023³â
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦Ç° À¯Çüº° ºÎ¹® ºÐ¼® 2019-2023³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : Æ®·£½ºÆå¼Ç ±â¼ú ¼¼°è ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô Âü¿©¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå »óȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
¹ÙÀÌ·¯½º º¤ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹°¸®Àû Æ®·£½ºÆå¼Ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
»ýÈÇп¡ ±â¹ÝÇÑ Æ®·£½ºÆå¼Ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : À¯Çüº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀÓ»ó½ÃÇè¼öʱâ°ü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Çмú¿¬±¸±â°ü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç° À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : Á¦Ç° À¯Çüº°
ŰƮ¿Í ½Ã¾à : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àåºñ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Á¦Ç° À¯Çüº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Altogen Biosystems
Bio Rad Laboratories Inc.
Danaher Corp.
GENLANTIS
Lonza Group Ltd.
MaxCyte Inc.
Merck KGaA
Mirus Bio LLC
OZ Biosciences
Promega Corp.
QIAGEN N.V.
Sartorius AG
SignaGen Laboratories
Takara Holdings Inc.
Thermo Fisher Scientific Inc.
Á¦16Àå ºÎ·Ï
ksm
The transfection technologies market is forecasted to grow by USD 746.2 mn during 2024-2029, accelerating at a CAGR of 9.7% during the forecast period. The report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, continued developments in transfection technologies by market companies, and growing adoption of crispr/cas9 gene editing technology.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 9.5%
CAGR 9.7%
Incremental Value $746.2 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's transfection technologies market is segmented as below:
By Type
Viral-vector
Physical transfection
Biochemical based transfection
By End-user
Pharmaceutical and biotechnology companies
Contract research organizations
Academic and research institutes
By Product Type
Kits and reagents
Equipment
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increased use of dual-reporter assays and co-transfection experiments as one of the prime reasons driving the transfection technologies market growth during the next few years. Also, optimization of transfection efficiency and growing focus on high-throughput transfection screening will lead to sizable demand in the market.
The report on the transfection technologies market covers the following areas:
Transfection Technologies Market sizing
Transfection Technologies Market forecast
Transfection Technologies Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection technologies market vendors that include Altogen Biosystems, Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., GENLANTIS, ibidi GmbH, Inovio Pharmaceuticals Inc., Kytopen Corp., Life Technologies India Pvt Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, Promega Corp., QIAGEN N.V., RJH BIOSCIENCES, Sartorius AG, SignaGen Laboratories, STEMCELL Technologies Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc.. Also, the transfection technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Transfection Technologies Market 2019 - 2023
Historic Market Size - Data Table on Global Transfection Technologies Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Transfection Technologies Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Viral-vector - Market size and forecast 2024-2029
Chart on Viral-vector - Market size and forecast 2024-2029 ($ million)
Data Table on Viral-vector - Market size and forecast 2024-2029 ($ million)
Chart on Viral-vector - Year-over-year growth 2024-2029 (%)
Data Table on Viral-vector - Year-over-year growth 2024-2029 (%)
8.4 Physical transfection - Market size and forecast 2024-2029
Chart on Physical transfection - Market size and forecast 2024-2029 ($ million)
Data Table on Physical transfection - Market size and forecast 2024-2029 ($ million)
Chart on Physical transfection - Year-over-year growth 2024-2029 (%)
Data Table on Physical transfection - Year-over-year growth 2024-2029 (%)
8.5 Biochemical based transfection - Market size and forecast 2024-2029
Chart on Biochemical based transfection - Market size and forecast 2024-2029 ($ million)
Data Table on Biochemical based transfection - Market size and forecast 2024-2029 ($ million)
Chart on Biochemical based transfection - Year-over-year growth 2024-2029 (%)
Data Table on Biochemical based transfection - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 Contract research organizations - Market size and forecast 2024-2029
Chart on Contract research organizations - Market size and forecast 2024-2029 ($ million)
Data Table on Contract research organizations - Market size and forecast 2024-2029 ($ million)
Chart on Contract research organizations - Year-over-year growth 2024-2029 (%)
Data Table on Contract research organizations - Year-over-year growth 2024-2029 (%)
9.5 Academic and research institutes - Market size and forecast 2024-2029
Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Product Type
10.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
10.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
10.3 Kits and reagents - Market size and forecast 2024-2029
Chart on Kits and reagents - Market size and forecast 2024-2029 ($ million)
Data Table on Kits and reagents - Market size and forecast 2024-2029 ($ million)
Chart on Kits and reagents - Year-over-year growth 2024-2029 (%)
Data Table on Kits and reagents - Year-over-year growth 2024-2029 (%)
10.4 Equipment - Market size and forecast 2024-2029
Chart on Equipment - Market size and forecast 2024-2029 ($ million)
Data Table on Equipment - Market size and forecast 2024-2029 ($ million)
Chart on Equipment - Year-over-year growth 2024-2029 (%)
Data Table on Equipment - Year-over-year growth 2024-2029 (%)
10.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Altogen Biosystems
Altogen Biosystems - Overview
Altogen Biosystems - Product / Service
Altogen Biosystems - Key offerings
SWOT
15.5 Bio Rad Laboratories Inc.
Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
SWOT
15.6 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT
15.7 GENLANTIS
GENLANTIS - Overview
GENLANTIS - Product / Service
GENLANTIS - Key offerings
SWOT
15.8 Lonza Group Ltd.
Lonza Group Ltd. - Overview
Lonza Group Ltd. - Business segments
Lonza Group Ltd. - Key news
Lonza Group Ltd. - Key offerings
Lonza Group Ltd. - Segment focus
SWOT
15.9 MaxCyte Inc.
MaxCyte Inc. - Overview
MaxCyte Inc. - Product / Service
MaxCyte Inc. - Key offerings
SWOT
15.10 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
15.11 Mirus Bio LLC
Mirus Bio LLC - Overview
Mirus Bio LLC - Product / Service
Mirus Bio LLC - Key offerings
SWOT
15.12 OZ Biosciences
OZ Biosciences - Overview
OZ Biosciences - Product / Service
OZ Biosciences - Key offerings
SWOT
15.13 Promega Corp.
Promega Corp. - Overview
Promega Corp. - Product / Service
Promega Corp. - Key offerings
SWOT
15.14 QIAGEN N.V.
QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings
SWOT
15.15 Sartorius AG
Sartorius AG - Overview
Sartorius AG - Business segments
Sartorius AG - Key news
Sartorius AG - Key offerings
Sartorius AG - Segment focus
SWOT
15.16 SignaGen Laboratories
SignaGen Laboratories - Overview
SignaGen Laboratories - Product / Service
SignaGen Laboratories - Key offerings
SWOT
15.17 Takara Holdings Inc.
Takara Holdings Inc. - Overview
Takara Holdings Inc. - Business segments
Takara Holdings Inc. - Key offerings
Takara Holdings Inc. - Segment focus
SWOT
15.18 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations